FHL3: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
[[Category:Muscular dystrophy]] | [[Category:Muscular dystrophy]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 17:06, 10 February 2025
FHL3 (Four and a half LIM domains 3) is a protein that in humans is encoded by the FHL3 gene. It is a member of the Four and a half LIM domains protein family, which is a group of proteins characterized by the presence of four LIM domains and an additional half LIM domain.
Function
FHL3 is a cytosolic protein that may be involved in specific cytoskeletal structures. This protein binds to the Rho family of GTPases, and may stimulate Rho-dependent signal transduction pathways. It is involved in the organization of actin filaments and in cell shape and motility.
Clinical significance
Mutations in the FHL3 gene have been associated with reducing the risk of developing muscular dystrophy, specifically X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD).
See also
References
<references />
